4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-025374
CHIEF OPERATING OFFICER sold 17,000 shares at $26.87 ($456,790)
- CHIEF OPERATING OFFICER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tessari Eben CHIEF OPERATING OFFICER | 2024-10-15 | Option exercise 10b5-1 | +10,000 | $1.59 | $15,900 | 126,975 | D |
| Tessari Eben CHIEF OPERATING OFFICER | 2024-10-15 | Sale 10b5-1 | −17,000 | $26.87 | $456,790 | 109,975 | D |
| Derivatives | |||||||
| Tessari Eben CHIEF OPERATING OFFICER | 2024-10-15 | Option exercise · Share Option 10b5-1 | −10,000 | 26,017 | D | ||
| Open-market sales · 17,000 sh · avg $26.87 · $456,790 | |||||||
Loading xslF345X05/form4-10172024_081035.xml…